摘要 |
<p>1426910 Aminoglycoside antibiotics ZAIDAN HOJIN BISEIBUTSU KAGAKU KENKYU KAI 30 Nov 1973 [8 Dec 1972] 55685/73 Heading C2C The invention comprises 3<SP>1</SP>-deoxy-vistamycin, its 6<SP>1</SP>-N-C 1-4 -alkyl derivatives, the 3<SP>1</SP>-deoxy-6<SP>1</SP>- N-C 1-4 -alkyl derivatives of neamine and kanamycin B, and their pharmaceutically acceptable acid addition salts. In examples, these compounds, 3<SP>1</SP> - deoxy - neamine and 31 - deoxy kanamycin B are prepared by protecting all of the amino groups in kanamycin B, neamine or vistamycin, thus forming corresponding polycarbamates, poly - arylimines or poly - benzamides, and some of the OH groups by forming cyclic ketals (in which unprotected OH groups may be esterified), then forming a corresponding 3<SP>1</SP> - tosylate or mesylate (in which a further OH group may be simultaneously tosylated or mesylated), and reacting these sulphonates with alkali metal, bromide or iodide giving the 3<SP>1</SP>- bromo- or 3<SP>1</SP> - iodo - 3<SP>1</SP> - deoxy compounds which are reduced to the desired compounds, the protecting group being generally removed in a final step; 3<SP>1</SP>-deoxy-6<SP>1</SP>-N-methyl derivatives are made by reducing the corresponding 3<SP>1</SP>- deoxy - 6<SP>1</SP> - N - benzylory compounds and purifying the desired products by means of intermediate poly - anisylimino - 3<SP>1</SP> - deoxy - 61- N-methyl derivatives. Therapeutic compositions for oral, parenteral or topical administration comprise the new compounds, which are active against grampositive and gram-negative bacteria.</p> |